KANEKA KanCapA™ 3G represents a new cellulose-based protein A resin with a high dynamic binding capacity and an outstanding impurity removal characteristics due to its newly engineered protein A ligand.
> Enhanced binding capacity
> Excellent elution profile
> Unique impurity removal properties
KANEKA KanCapA™ 3G shows enhanced binding capacity, mainly at longer residence times, which makes it suitable for monoclonal antibody purification from high titer feedstocks.
KANEKA KanCapA™ 3G’s ligand was designed for efficient elution of monoclonal antibodies and their Fc fusion derivatives under mild acidic conditions.
KANEKA KanCapA™ 3G has a better potential for impurity removal compared to current resins available on the market.
| Product Name | Format | Volume | Catalog Number |
|---|---|---|---|
| KANEKA KanCapA™ 3G | Prepacked Column | 1 mL | KPA03-C001 |
| 5 mL | KPA03-C005 | ||
| RoboColumn® | 200µL x 8 row | KPA03-S200 | |
| 600µL x 8 row | KPA03-S600 | ||
| Bulk Resin | 25 mL | KPA03-B025 | |
| 500 mL | KPA03-B500 | ||
| 5 L | KPA03-B05K | ||
| 10 L | KPA03-B10K |
1. Evaluation of dynamic binding capacity, host cell protein removal and aggregation reduction properties of KANEKA KanCapA™ 3G protein A affinity resin (Download the technical note)
2. Pressure flow characteristics & scalability of Kaneka KanCapA™ and
KanCapA™ 3G (Download the technical note)
Would you like to get a PDF version? Download the KANEKA KanCapA™ 3G product brochure.
Do you want to discuss with an expert?
We will treat all your details with utmost confidentiality.
Click to close
